CNBX PHARMACEUTICALS INC. (CNBX) Operating margin 2016–2024
CNBX PHARMACEUTICALS INC. (CNBX) operating margin by fiscal year — reported operating income divided by reported revenue.
-448.3%FY2024 · since FY2016: -249.5% → -448.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -448.3% | -221.2 pp |
| FY2023 | -227.1% | +9633.3 pp |
| FY2022 | -9860.4% | — |
| FY2020 | -42524.1% | -8961.1 pp |
| FY2019 | -33563.0% | +6107.1 pp |
| FY2018 | -39670.1% | -7054.0 pp |
| FY2017 | -32616.1% | -32366.6 pp |
| FY2016 | -249.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CNBX financial trends
CNBX RevenueCNBX Net incomeCNBX Net marginCNBX Gross profitCNBX Gross marginCNBX Operating incomeCNBX Operating cash flowCNBX Free cash flowCNBX Capital expendituresCNBX Return on equityCNBX Stock buybacksCNBX Dividends paidCNBX Total assetsCNBX Total liabilitiesCNBX Shareholders’ equityCNBX overview →